GUGGENHEIM CREDIT INCOME FUND 2019

2024 Q3 Form 10-Q Financial Statement

#000139834424014536 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $562.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.063M
YoY Change -59.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $65.05K
YoY Change -19.35%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.737K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.998M
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2024 Q3 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
GCIF Professional Services Fees
ProfessionalServicesFees
33316 usd
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
348000000 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 GCIF Accounts Payable Related Party Current And Noncurrent
AccountsPayableRelatedPartyCurrentAndNoncurrent
usd
GCIF Gross Proceeds From Public Offerings Shares
GrossProceedsFromPublicOfferingsShares
shares
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
GCIF Dealer Manager Fees And Commissions Shares
DealerManagerFeesAndCommissionsShares
shares
us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
usd
GCIF Dealer Manager Fees And Commissions Shares
DealerManagerFeesAndCommissionsShares
shares
GCIF Net Proceeds To Company From Public Offerings Shares
NetProceedsToCompanyFromPublicOfferingsShares
shares
GCIF Net Proceeds To Company From Public Offerings
NetProceedsToCompanyFromPublicOfferings
usd
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
shares
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
GCIF Net Realized Gains From Investment In Gcif
NetRealizedGainsFromInvestmentInGcif
GCIF Net Realized Gains From Investment In Gcif
NetRealizedGainsFromInvestmentInGcif
GCIF Investment Company Distributions From Net Investment Income
InvestmentCompanyDistributionsFromNetInvestmentIncome
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1736284 shares
CY2024Q2 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
5046351 shares
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5316455 usd
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
5046351 shares
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
8258643 usd
CY2024Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
2501530 usd
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
5476803 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
561957 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
706284 usd
CY2024Q2 us-gaap Assets
Assets
3063487 usd
CY2023Q4 us-gaap Assets
Assets
6183087 usd
CY2023Q4 GCIF Accounts Payable Related Party Current And Noncurrent
AccountsPayableRelatedPartyCurrentAndNoncurrent
11458 usd
CY2024Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
37124 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
50287 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
27928 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
24361 usd
CY2024Q2 us-gaap Liabilities
Liabilities
65052 usd
CY2023Q4 us-gaap Liabilities
Liabilities
86106 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
2998435 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
6096981 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
348000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1736284 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1736284 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1736284 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1736284 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1737 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1737 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7123640 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10092686 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4126942 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3997442 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
2998435 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
6096981 usd
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.73
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
3.51
CY2023Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
60660 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
35159 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
145035 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
60660 usd
us-gaap Investment Income Net
InvestmentIncomeNet
35159 usd
us-gaap Investment Income Net
InvestmentIncomeNet
145035 usd
CY2023Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
3669 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
7500 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
7298 usd
CY2023Q2 GCIF Related Party Reimbursements
RelatedPartyReimbursements
10759 usd
GCIF Related Party Reimbursements
RelatedPartyReimbursements
22733 usd
GCIF Related Party Reimbursements
RelatedPartyReimbursements
20646 usd
CY2023Q2 us-gaap Trustee Fees
TrusteeFees
748 usd
us-gaap Trustee Fees
TrusteeFees
1496 usd
us-gaap Trustee Fees
TrusteeFees
1488 usd
CY2023Q2 GCIF Professional Services Fees
ProfessionalServicesFees
25078 usd
GCIF Professional Services Fees
ProfessionalServicesFees
-6109 usd
CY2023Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
27434 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
55445 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
54185 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3285 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-11085 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
9762 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
70973 usd
us-gaap Operating Expenses
OperatingExpenses
131575 usd
us-gaap Operating Expenses
OperatingExpenses
67746 usd
CY2023Q2 GCIF Net Investment Income Loss
NetInvestmentIncomeLoss
-10313 usd
GCIF Net Investment Income Loss
NetInvestmentIncomeLoss
-96416 usd
GCIF Net Investment Income Loss
NetInvestmentIncomeLoss
77289 usd
CY2023Q2 GCIF Net Change In Unrealized Depreciation From Investment
NetChangeInUnrealizedDepreciationFromInvestment
108549 usd
GCIF Net Change In Unrealized Depreciation From Investment
NetChangeInUnrealizedDepreciationFromInvestment
33084 usd
GCIF Net Change In Unrealized Depreciation From Investment
NetChangeInUnrealizedDepreciationFromInvestment
113708 usd
CY2023Q2 GCIF Net Realized And Unrealized Losses On Investment
NetRealizedAndUnrealizedLossesOnInvestment
-108549 usd
GCIF Net Realized And Unrealized Losses On Investment
NetRealizedAndUnrealizedLossesOnInvestment
-33084 usd
GCIF Net Realized And Unrealized Losses On Investment
NetRealizedAndUnrealizedLossesOnInvestment
-113708 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-118862 usd
us-gaap Net Income Loss
NetIncomeLoss
-129500 usd
us-gaap Net Income Loss
NetIncomeLoss
-36419 usd
CY2023Q2 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.01
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.06
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.04
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1736284 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1736284 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1736284 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1736284 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1736284 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1736284 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1736284 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1736284 shares
CY2023Q2 GCIF Distribution Per Common Share Outstandings
DistributionPerCommonShareOutstandings
2.27
GCIF Distribution Per Common Share Outstandings
DistributionPerCommonShareOutstandings
1.71
GCIF Distribution Per Common Share Outstandings
DistributionPerCommonShareOutstandings
1.98
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6096981 usd
CY2024Q1 us-gaap Net Investment Income
NetInvestmentIncome
-68058 usd
CY2024Q1 GCIF Net Change In Unrealized Depreciation From Investment In Gcif
NetChangeInUnrealizedDepreciationFromInvestmentInGcif
127705 usd
CY2024Q1 GCIF Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
59647 usd
CY2024Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
59647 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6156628 usd
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
-28358 usd
CY2024Q2 GCIF Net Change In Unrealized Depreciation From Investment In Gcif
NetChangeInUnrealizedDepreciationFromInvestmentInGcif
-160789 usd
CY2024Q2 GCIF Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
-189147 usd
CY2024Q2 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
2969046 usd
CY2024Q2 GCIF Net Decrease In Net Assets Resulting From Shareholder Distributions
NetDecreaseInNetAssetsResultingFromShareholderDistributions
-2969046 usd
CY2024Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-3158193 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2998435 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12925546 usd
CY2023Q1 us-gaap Net Investment Income
NetInvestmentIncome
87603 usd
CY2023Q1 GCIF Net Change In Unrealized Depreciation From Investment In Gcif
NetChangeInUnrealizedDepreciationFromInvestmentInGcif
-5159 usd
CY2023Q1 GCIF Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
82444 usd
CY2023Q1 GCIF Distributions From Earnings
DistributionsFromEarnings
-99947 usd
CY2023Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
3337906 usd
CY2023Q1 GCIF Net Decrease In Net Assets Resulting From Shareholder Distributions
NetDecreaseInNetAssetsResultingFromShareholderDistributions
-3437853 usd
CY2023Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-3355409 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9570137 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
-10313 usd
CY2023Q2 GCIF Net Change In Unrealized Depreciation From Investment In Gcif
NetChangeInUnrealizedDepreciationFromInvestmentInGcif
-108549 usd
CY2023Q2 GCIF Net Increase In Net Assets Resulting From Operations
NetIncreaseInNetAssetsResultingFromOperations
-118862 usd
CY2023Q2 GCIF Distributions From Earnings
DistributionsFromEarnings
251 usd
CY2023Q2 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
1962252 usd
CY2023Q2 GCIF Net Decrease In Net Assets Resulting From Shareholder Distributions
NetDecreaseInNetAssetsResultingFromShareholderDistributions
-1962001 usd
CY2023Q2 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-2080863 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7489274 usd
us-gaap Net Income Loss
NetIncomeLoss
-129500 usd
us-gaap Net Income Loss
NetIncomeLoss
-36419 usd
GCIF Proceeds From Liquidation Distribution
ProceedsFromLiquidationDistribution
2942187 usd
GCIF Proceeds From Liquidation Distribution
ProceedsFromLiquidationDistribution
5254561 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-33085 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-113708 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-11458 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-118 usd
GCIF Increase Decrease Professional And Contract Services Expenses
IncreaseDecreaseProfessionalAndContractServicesExpenses
-13163 usd
GCIF Increase Decrease Professional And Contract Services Expenses
IncreaseDecreaseProfessionalAndContractServicesExpenses
-54938 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3568 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-10327 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2824719 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5266467 usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
2969046 usd
us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
5399854 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2969046 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5399854 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-144327 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-133387 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
706284 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
990500 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
561957 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
857113 usd
CY2018Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
958600000 usd
CY2024Q2 GCIF Outstanding Common Shares Percentage
OutstandingCommonSharesPercentage
0.1972 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zxeQU5QPZskj" style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_864_zPKOtv7uOGub">Use of Estimates</span></i></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities at the date of the financial statements, (ii) the reported amounts of income and expenses during the reported period and (iii) disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ materially from those estimates under different assumptions and conditions.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
GCIF Investment Company Taxable Income Percentage
InvestmentCompanyTaxableIncomePercentage
0.90 pure
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.98 pure
GCIF Capital Gain Net Income Percentage
CapitalGainNetIncomePercentage
0.982 pure
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.04 pure
CY2024Q2 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
5046351 shares
GCIF Investment Weighted Average Shares Owned Quarter
InvestmentWeightedAverageSharesOwnedQuarter
5046351 shares
GCIF Investment Weighted Average Shares Owned Year
InvestmentWeightedAverageSharesOwnedYear
5046351 shares
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
5316455 usd
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
2501530 usd
CY2024Q2 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.834 pure
CY2023Q4 us-gaap Investment Owned Balance Shares
InvestmentOwnedBalanceShares
5046351 shares
CY2023 GCIF Investment Weighted Average Shares Owned Quarter
InvestmentWeightedAverageSharesOwnedQuarter
5046351 shares
CY2023 GCIF Investment Weighted Average Shares Owned Year
InvestmentWeightedAverageSharesOwnedYear
5046351 shares
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
8258643 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5476803 usd
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.898 pure
GCIF Organization And Offering Expenses Percentage
OrganizationAndOfferingExpensesPercentage
0.015 pure
GCIF Average Net Assets Attributable To Its Common Shares
AverageNetAssetsAttributableToItsCommonShares
0.0173 pure
CY2024Q2 GCIF Total Amount Of Expense Support Received For Reimbursement
TotalAmountOfExpenseSupportReceivedForReimbursement
967781 usd
GCIF Gross Proceeds From Public Offerings Shares
GrossProceedsFromPublicOfferingsShares
1959348 shares
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
50158691 usd
us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
890172 usd
GCIF Net Proceeds To Company From Public Offerings Shares
NetProceedsToCompanyFromPublicOfferingsShares
1959348 shares
GCIF Net Proceeds To Company From Public Offerings
NetProceedsToCompanyFromPublicOfferings
49268519 usd
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
278752 shares
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
6762060 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
2238100 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
56030579 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
25.03
us-gaap Distribution Made To Limited Liability Company Llc Member Distributions Paid Per Unit
DistributionMadeToLimitedLiabilityCompanyLLCMemberDistributionsPaidPerUnit
1.71000
us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
2969046 usd
us-gaap Distribution Made To Limited Liability Company Llc Member Distributions Paid Per Unit
DistributionMadeToLimitedLiabilityCompanyLLCMemberDistributionsPaidPerUnit
3.11000
us-gaap Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid
DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid
5399854 usd
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
3.51
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
7.44
GCIF Net Investment Income Per Share
NetInvestmentIncomePerShare
-0.06
GCIF Net Investment Income Per Share
NetInvestmentIncomePerShare
0.04
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.01
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.06
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.07
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.02
GCIF Investment Company Distributions From Net Investment Income
InvestmentCompanyDistributionsFromNetInvestmentIncome
-0.06
us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-1.71
us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-3.05
GCIF Investment Company Net Decrease Resulting From Distributions
InvestmentCompanyNetDecreaseResultingFromDistributions
-1.71
GCIF Investment Company Net Decrease Resulting From Distributions
InvestmentCompanyNetDecreaseResultingFromDistributions
-3.11
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
1.73
CY2023Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.31
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0212 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0061 pure
CY2024Q2 us-gaap Assets Net
AssetsNet
2998435 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
7489274 usd
GCIF Average Net Assets
AverageNetAssets
5651494 usd
GCIF Average Net Assets
AverageNetAssets
10700957 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1736284 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1736284 shares
GCIF Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
1736284 shares
GCIF Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
1736284 shares
GCIF Ratios To Average Net Assets Total Operating Expenses
RatiosToAverageNetAssetsTotalOperatingExpenses
0.0233 pure
GCIF Ratios To Average Net Assets Total Operating Expenses
RatiosToAverageNetAssetsTotalOperatingExpenses
0.0063 pure
GCIF Ratios To Average Net Assets Net Expenses Reimbursements
RatiosToAverageNetAssetsNetExpensesReimbursements
0.0233 pure
GCIF Ratios To Average Net Assets Net Expenses Reimbursements
RatiosToAverageNetAssetsNetExpensesReimbursements
0.0063 pure
GCIF Ratios To Average Net Assets Net Investment Income
RatiosToAverageNetAssetsNetInvestmentIncome
-0.0171 pure
GCIF Ratios To Average Net Assets Net Investment Income
RatiosToAverageNetAssetsNetInvestmentIncome
0.0072 pure

Files In Submission

Name View Source Status
0001398344-24-014536-index-headers.html Edgar Link pending
0001398344-24-014536-index.html Edgar Link pending
0001398344-24-014536.txt Edgar Link pending
0001398344-24-014536-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fp0089537-1_01.jpg Edgar Link pending
fp0089537-3_01.jpg Edgar Link pending
fp0089537-3_10qixbrl.htm Edgar Link pending
fp0089537-3_ex311.htm Edgar Link pending
fp0089537-3_ex312.htm Edgar Link pending
fp0089537-3_ex32.htm Edgar Link pending
fp0089537-3_ex99.htm Edgar Link pending
gcif-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gcif-20240630_def.xml Edgar Link unprocessable
gcif-20240630_lab.xml Edgar Link unprocessable
gcif-20240630_pre.xml Edgar Link unprocessable
gcif-20240630_cal.xml Edgar Link unprocessable
fp0089537-3_10qixbrl_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending